Source: BioPortfolio

IBI: Interface Biologics Inc Medical Equipment Deals and Alliances Profile Report Updated 08022018 Prices from USD $250

SummaryInterface Biologics Inc IBI is a developer transformative biomedical polymer technology. The company offers antithrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Tom Reeves's photo - President & CEO of Interfacebiologics

President & CEO

Tom Reeves

CEO Approval Rating

69/100

Read more